Detalles de la búsqueda
1.
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.
Cancer
; 125(18): 3184-3197, 2019 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31150120
2.
Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer.
Eur J Cancer
; 200: 113560, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38306841
3.
Metronomic adjuvant chemotherapy evaluation in locally advanced head and neck cancers post radical chemoradiation - a randomised trial.
Lancet Reg Health Southeast Asia
; 12: 100162, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37384061
4.
Long term outcomes of phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/early failure oral cancer.
Lancet Reg Health Southeast Asia
; 12: 100143, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37384062
5.
Repurposing pantoprazole in combination with systemic therapy in advanced head and neck squamous cell carcinoma: a phase I/II randomized study.
Med Oncol
; 41(1): 26, 2023 Dec 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38129716
6.
Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study.
J Clin Oncol
; 41(2): 222-232, 2023 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36265101
7.
Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation.
J Clin Oncol
; 41(13): 2350-2361, 2023 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36706347
8.
Quality of life in patients with locally advanced head and neck squamous cell carcinoma undergoing concurrent chemoradiation with once-a-week versus once-every-3-weeks cisplatin.
Cancer Med
; 11(21): 3939-3948, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35343648
9.
Audit of screen failure in 15 randomised studies from a low and middle-income country.
Ecancermedicalscience
; 16: 1476, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36819805
10.
RMAC study: A randomized study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiation.
Oral Oncol
; 128: 105816, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35367787
11.
Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial.
Lancet Glob Health
; 8(9): e1213-e1222, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32827483
12.
Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral Cancer.
J Clin Oncol
; 37(32): 3032-3041, 2019 11 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31539316
13.
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial.
J Clin Oncol
; 36(11): 1064-1072, 2018 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29220295
14.
Long term outcomes of a randomized controlled clinical trial comparing the efficacy of Cabazitaxel versus docetaxel as second-line or above therapy in recurrent head and neck cancer.
Oral Oncol
; 134: 106085, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36126602
Resultados
1 -
14
de 14
1
Próxima >
>>